# SPIRIVA
> **NDA021395** · New Drug Application · Sponsor: BOEHRINGER INGELHEIM · Approved 2004-01-30
## Drug
- **FDA Application Number:** NDA021395
- **Application type:** New Drug Application
- **Brand name:** SPIRIVA
- **Generic name:** TIOTROPIUM BROMIDE
- **Active ingredients:** TIOTROPIUM BROMIDE
- **Dosage form:** POWDER
- **Route:** INHALATION
- **Marketing status:** Prescription
- **Sponsor:** BOEHRINGER INGELHEIM
- **Manufacturer:** Boehringer Ingelheim Pharmaceuticals, Inc.
- **First approval:** 2004-01-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021395)
---
*AI Analytics · CC0 1.0*